These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 22665953)

  • 1. Lipopolysaccharides: from Erinyes to Charites.
    Focà A; Liberto MC; Quirino A; Matera G
    Mediators Inflamm; 2012; 2012():684274. PubMed ID: 22665953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New data on the chemical structure of lipopolysaccharides and the practical prospects].
    Iarovaia LM; Aleshkin VA
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Mar; (3):73-8. PubMed ID: 1872103
    [No Abstract]   [Full Text] [Related]  

  • 3. Biochemistry and cell biology of bacterial endotoxins.
    Holst O; Ulmer AJ; Brade H; Flad HD; Rietschel ET
    FEMS Immunol Med Microbiol; 1996 Dec; 16(2):83-104. PubMed ID: 8988390
    [No Abstract]   [Full Text] [Related]  

  • 4. The physicochemistry of endotoxins in relation to bioactivity.
    Gutsmann T; Schromm AB; Brandenburg K
    Int J Med Microbiol; 2007 Sep; 297(5):341-52. PubMed ID: 17452014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial endotoxin: Chemical constitution, biological recognition, host response, and immunological detoxification.
    Rietschel ET; Brade H; Holst O; Brade L; Müller-Loennies S; Mamat U; Zähringer U; Beckmann F; Seydel U; Brandenburg K; Ulmer AJ; Mattern T; Heine H; Schletter J; Loppnow H; Schönbeck U; Flad HD; Hauschildt S; Schade UF; Di Padova F; Kusumoto S; Schumann RR
    Curr Top Microbiol Immunol; 1996; 216():39-81. PubMed ID: 8791735
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition by Coxiella burnetii of ascites tumour formation in mice.
    Kazár J; Schramek S
    Acta Virol; 1979 May; 23(3):267-70. PubMed ID: 41443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial endotoxin: molecular relationships between structure and activity.
    Rietschel ET; Seydel U; Zähringer U; Schade UF; Brade L; Loppnow H; Feist W; Wang MH; Ulmer AJ; Flad HD
    Infect Dis Clin North Am; 1991 Dec; 5(4):753-79. PubMed ID: 1723739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of cytokines in endotoxic shock and in endotoxin hypersensitivity].
    Freudenberg MA; Ness T; Kumazawa Y; Galanos C
    Immun Infekt; 1993 Apr; 21(2):40-4. PubMed ID: 8340136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endotoxicity does not limit the use of bacterial ghosts as candidate vaccines.
    Mader HJ; Szostak MP; Hensel A; Lubitz W; Haslberger AG
    Vaccine; 1997 Feb; 15(2):195-202. PubMed ID: 9066038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Putting endotoxin to work for us: monophosphoryl lipid A as a safe and effective vaccine adjuvant.
    Casella CR; Mitchell TC
    Cell Mol Life Sci; 2008 Oct; 65(20):3231-40. PubMed ID: 18668203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experimental model of high-dosage immunological tolerance to Shigella sonnei lipopolysaccharide].
    Borisov VA; Gofman IL
    Mikrobiol Zh (1978); 1980; 42(6):723-6. PubMed ID: 7007829
    [No Abstract]   [Full Text] [Related]  

  • 12. Bound to shock: protection from lethal endotoxemic shock by a novel, nontoxic, alkylpolyamine lipopolysaccharide sequestrant.
    Sil D; Shrestha A; Kimbrell MR; Nguyen TB; Adisechan AK; Balakrishna R; Abbo BG; Malladi S; Miller KA; Short S; Cromer JR; Arora S; Datta A; David SA
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2811-9. PubMed ID: 17548488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular structure of lipid A, the endotoxic center of bacterial lipopolysaccharides.
    Zähringer U; Lindner B; Rietschel ET
    Adv Carbohydr Chem Biochem; 1994; 50():211-76. PubMed ID: 7942255
    [No Abstract]   [Full Text] [Related]  

  • 14. Modeling the LPS neutralization activity of anti-endotoxins.
    Thippakorn C; Suksrichavalit T; Nantasenamat C; Tantimongcolwat T; Isarankura-Na-Ayudhya C; Naenna T; Prachayasittikul V
    Molecules; 2009 May; 14(5):1869-88. PubMed ID: 19471207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical structure, molecular conformation, and bioactivity of endotoxins.
    Seydel U; Schromm AB; Blunck R; Brandenburg K
    Chem Immunol; 2000; 74():5-24. PubMed ID: 10608079
    [No Abstract]   [Full Text] [Related]  

  • 16. Mechanisms of neutralization of endotoxin by monoclonal antibodies to O and R determinants of lipopolysaccharide.
    Sagawa T; Hitsumoto Y; Kanoh M; Utsumi S; Kimura S
    Adv Exp Med Biol; 1990; 256():341-4. PubMed ID: 2183557
    [No Abstract]   [Full Text] [Related]  

  • 17. Conformation and fluidity of endotoxins as determinants of biological activity.
    Brandenburg K; Schromm AB; Koch MH; Seydel U
    Prog Clin Biol Res; 1995; 392():167-82. PubMed ID: 8524923
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pathophysiological role of endotoxins, a common denominator to various diseases].
    Amoureux MC
    Pathol Biol (Paris); 2004 Sep; 52(7):415-22. PubMed ID: 15336435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological activities of endotoxins detoxified by alkylation.
    Chedid L; Audibert F; Bona C; Damais C; Parant F; Parant M
    Infect Immun; 1975 Oct; 12(4):714-21. PubMed ID: 1238369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulation by bacterial endotoxin.
    Burrell R
    Crit Rev Microbiol; 1990; 17(3):189-208. PubMed ID: 1689164
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.